Recent evidence, using the GL261/C57Bl/6 mouse glioma implantation model, has demonstrated a significant increase in Pyk2 signaling activity in regrown tumors after surgical resection, despite no difference in the basal expression levels of total Pyk2 when compared to primary implanted untreated tumors [24]. Here, PTK2B is linked to central nervous system cancer.